
Quanterix Corporation QTRX
$ 3.29
-0.3%
Quarterly report 2026-Q1
added 05-06-2026
Quanterix Corporation Interest Expense 2011-2026 | QTRX
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Quanterix Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 157 K | -136 K | 2.52 M | -277 K | 1.26 M | -49 K | -10 K | -7 K | -63 K | -164 K | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.52 M | -277 K | 323 K |
Quarterly Interest Expense Quanterix Corporation
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.4 M | -178 K | 49 K | 61 K | - | 5 K | -9 K | 226 K | - | 2.03 M | -154 K | 8 K | - | -101 K | -358 K | -217 K | - | -305 K | 1.98 M | -194 K | 155 K | -26 K | -11 K | -167 K | 139 K | -34 K | -68 K | -47 K | 81 K | -25 K | -48 K | 24 K | -73 K | 13 K | 77 K | 255 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 21.4 M | -358 K | 766 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
45.9 M | - | - | $ 1.05 B | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.6 | 4.2 % | $ 135 M | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.22 | 2.78 % | $ 1.35 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 11.47 | 3.33 % | $ 325 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 17.12 | 0.47 % | $ 402 M | ||
|
LivaNova PLC
LIVN
|
664 K | $ 66.26 | 15.05 % | $ 3.61 B | ||
|
Delcath Systems
DCTH
|
-70 K | $ 11.26 | -2.34 % | $ 403 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
78 K | - | 0.5 % | $ 219 M | ||
|
Myomo
MYO
|
-668 K | $ 0.85 | -2.78 % | $ 35.6 M | ||
|
Butterfly Network
BFLY
|
-13 K | $ 4.55 | -5.6 % | $ 963 M | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Orthofix Medical
OFIX
|
8.11 M | $ 12.19 | -2.01 % | $ 483 M | ||
|
Insulet Corporation
PODD
|
14.3 M | - | - | $ 10.6 B | ||
|
Globus Medical
GMED
|
3.41 M | $ 89.22 | -0.9 % | $ 12.1 B | ||
|
Sintx Technologies
SINT
|
31 K | $ 2.4 | -0.83 % | $ 6.66 M | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 37.32 | 1.86 % | $ 1.16 B | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 45.7 | -5.42 % | $ 1.34 B | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 86.29 | 0.51 % | $ 3 B | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 83.2 | 0.35 % | $ 48.7 B | ||
|
TransMedics Group
TMDX
|
3.87 M | - | - | $ 2.48 B | ||
|
Tandem Diabetes Care
TNDM
|
-13 M | - | - | $ 1.23 B | ||
|
LENSAR
LNSR
|
636 K | $ 5.39 | -1.73 % | $ 64.5 M |